Lizano-DĂez, I.; Aldalur-Uranga, I.; Figueiredo-Escribá, C.; Lastra, C.F.; Mariño, E.L.; Modamio, P.
Effects of the Off-Label Drug Prescription in the Paediatric Population in Spain from the Adoption of the Latest European Regulation: A Pre-Post Study. Pharmaceutics 2021, 13, 588.
https://doi.org/10.3390/pharmaceutics13040588
AMA Style
Lizano-DĂez I, Aldalur-Uranga I, Figueiredo-Escribá C, Lastra CF, Mariño EL, Modamio P.
Effects of the Off-Label Drug Prescription in the Paediatric Population in Spain from the Adoption of the Latest European Regulation: A Pre-Post Study. Pharmaceutics. 2021; 13(4):588.
https://doi.org/10.3390/pharmaceutics13040588
Chicago/Turabian Style
Lizano-DĂez, Irene, Itziar Aldalur-Uranga, Carlos Figueiredo-Escribá, Cecilia F. Lastra, Eduardo L. Mariño, and Pilar Modamio.
2021. "Effects of the Off-Label Drug Prescription in the Paediatric Population in Spain from the Adoption of the Latest European Regulation: A Pre-Post Study" Pharmaceutics 13, no. 4: 588.
https://doi.org/10.3390/pharmaceutics13040588
APA Style
Lizano-DĂez, I., Aldalur-Uranga, I., Figueiredo-Escribá, C., Lastra, C. F., Mariño, E. L., & Modamio, P.
(2021). Effects of the Off-Label Drug Prescription in the Paediatric Population in Spain from the Adoption of the Latest European Regulation: A Pre-Post Study. Pharmaceutics, 13(4), 588.
https://doi.org/10.3390/pharmaceutics13040588